rs121434272
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_001126128.2(PROK2):c.217C>T(p.Arg73Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000514 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000051 ( 0 hom. )
Consequence
PROK2
NM_001126128.2 missense
NM_001126128.2 missense
Scores
5
11
3
Clinical Significance
Conservation
PhyloP100: 6.30
Genes affected
PROK2 (HGNC:18455): (prokineticin 2) This gene encodes a protein expressed in the suprachiasmatic nucleus (SCN) circadian clock that may function as the output component of the circadian clock. The secreted form of the encoded protein may also serve as a chemoattractant for neuronal precursor cells in the olfactory bulb. Proteins from other vertebrates which are similar to this gene product were isolated based on homology to snake venom and secretions from frog skin, and have been shown to have diverse functions. Mutations in this gene are associated with Kallmann syndrome 4. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-71781472-G-A is Pathogenic according to our data. Variant chr3-71781472-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 3604.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROK2 | NM_001126128.2 | c.217C>T | p.Arg73Cys | missense_variant | 2/4 | ENST00000295619.4 | NP_001119600.1 | |
PROK2 | NM_021935.4 | c.217C>T | p.Arg73Cys | missense_variant | 2/3 | NP_068754.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROK2 | ENST00000295619.4 | c.217C>T | p.Arg73Cys | missense_variant | 2/4 | 1 | NM_001126128.2 | ENSP00000295619 | ||
PROK2 | ENST00000353065.7 | c.217C>T | p.Arg73Cys | missense_variant | 2/3 | 1 | ENSP00000295618 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152074Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
9
AN:
152074
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251420Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135900
GnomAD3 exomes
AF:
AC:
18
AN:
251420
Hom.:
AF XY:
AC XY:
12
AN XY:
135900
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461762Hom.: 0 Cov.: 30 AF XY: 0.0000674 AC XY: 49AN XY: 727192
GnomAD4 exome
AF:
AC:
74
AN:
1461762
Hom.:
Cov.:
30
AF XY:
AC XY:
49
AN XY:
727192
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74286
GnomAD4 genome
AF:
AC:
9
AN:
152074
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74286
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
8
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hypogonadotropic hypogonadism 4 with or without anosmia Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2008 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 18, 2017 | - - |
PROK2-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 28, 2024 | The PROK2 c.217C>T variant is predicted to result in the amino acid substitution p.Arg73Cys. This variant has been reported in the heterozygous, homozygous, or compound heterozygous state in patients affected with Kallmann syndrome and normosmic hypogonadotropic hypogonadism (Dodé et al. 2006. PubMed ID: 17054399; Cole et al. 2008. PubMed ID: 18559922; Leroy et al. 2008. PubMed ID: 18285834; Mao et al. 2015. PubMed ID: 26141714). This variant is expected to disrupt the formation of the disulfide bonds of the protein; in vitro functional analysis demonstrated that this variant resulted in a 7-fold decrease in calcium mobilization activity in the presence of PROK2 receptor (PROKR2) (Cole et al. 2008. PubMed ID: 18559922). This variant is reported in 0.039% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as likely pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2021 | ClinVar contains an entry for this variant (Variation ID: 3604). This missense change has been observed in individuals with clinical features of Kallman syndrome (PMID: 17054399, 18285834, 18559922, 26141714). This variant is present in population databases (rs121434272, ExAC 0.02%). This sequence change replaces arginine with cysteine at codon 73 of the PROK2 protein (p.Arg73Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects PROK2 function (PMID: 18559922). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
.;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;T
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L
MutationTaster
Benign
A;A
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
MVP
MPC
0.58
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at